Tradestie Institutional Equity Comparison Engine

HIBL vs HIBS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HIBS Overall Edge

HIBS Captures Institutional Edge (2โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Direxion Daily S&P 500 High Beta Bear 3X Shares (HIBS) driven by superior Momentum & Technical, Options & Structure. Fundamentally, HIBL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HIBS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HIBL sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against HIBS sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
HIBL N/M vs HIBS N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner HIBS
1Y +6.4% vs +294.8% ยท 52W Pos 17% vs 40%
Options & Structure Winner HIBS
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
HIBL NYSE Arca
Direxion Daily S&P 500 High Beta Bull 3X Shares
Institutional Equity
$62.12
-11.23% 1D
Market Cap N/A
1M Return -27.05%
1Y Return +6.41%
Forward P/E N/M
Unified AI Score
51.0 / 100 HOLD
Tech 50.0 Fund 54.0 Flow 50.0 Mom 60.0
HIBS NYSE Arca
Direxion Daily S&P 500 High Beta Bear 3X Shares
Institutional Equity
$24.20
+11.01% 1D
Market Cap N/A
1M Return +13.67%
1Y Return +294.78%
Forward P/E N/M
Unified AI Score
38.6 / 100 SELL
Tech 23.0 Fund 43.0 Flow 50.0 Mom 56.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HIBL +6.41% HIBS +294.78% Spread: +288.37 pp (HIBS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HIBL TTM Op. Margin: N/A HIBS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HIBL vs HIBS. Trailing 12-month operating profitability (HIBL N/A vs HIBS N/A) and valuation multiples (HIBL N/M vs HIBS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HIBL (2) vs HIBS (1)
Institutional Metric HIBL HIBS Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 17% ($47โ€“$138) 40% ($4โ€“$55) Stronger Trend HIBS
Beta / 30D Volatility Risk Regime 5.90ฮฒ ยท 154% Vol -5.90ฮฒ ยท 155% Vol Lower Realized Risk HIBL
Unified Institutional Score Composite Signal 51.0 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite HIBL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HIBL vs HIBS Buy Guide
HIBL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live HIBL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HIBS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live HIBS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HIBL nor HIBS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.